Propofol injection is used as an adjunct to spinal and epidural anesthesia, and it is used in conjunction with commonly used preoperative medications, neuromuscular blocking agents, inhaled anesthetics and analgesics, and no drug incompatibility has been encountered. It is used as a general anesthesia to complement regional anesthesia techniques, requiring lower doses. And often supplemental pain medication is required.
The global Propofol Injection for Operation General Anesthesia market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Propofol Injection for Operation General Anesthesia, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Propofol Injection for Operation General Anesthesia, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Propofol Injection for Operation General Anesthesia, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Propofol Injection for Operation General Anesthesia sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Propofol Injection for Operation General Anesthesia market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Specification, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Propofol Injection for Operation General Anesthesia sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xi'an Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Segment by Specification
10ml
20ml
50ml
Others
Segment by Application
Hopitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Specification, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Propofol Injection for Operation General Anesthesia in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Propofol Injection for Operation General Anesthesia manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Specification, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Specification, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Specification, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Specification, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol Injection for Operation General Anesthesia sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Propofol Injection for Operation General Anesthesia Product Introduction
1.2 Market by Specification
1.2.1 Global Propofol Injection for Operation General Anesthesia Market Size Growth Rate by Specification, 2019 VS 2023 VS 2030
1.2.2 10ml
1.2.3 20ml
1.2.4 50ml
1.2.5 Others
1.3 Market by Application
1.3.1 Global Propofol Injection for Operation General Anesthesia Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hopitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Propofol Injection for Operation General Anesthesia Sales Estimates and Forecasts 2019-2030
2.2 Global Propofol Injection for Operation General Anesthesia Revenue by Region
2.2.1 Global Propofol Injection for Operation General Anesthesia Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Propofol Injection for Operation General Anesthesia Revenue by Region (2019-2024)
2.2.3 Global Propofol Injection for Operation General Anesthesia Revenue by Region (2025-2030)
2.2.4 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Region (2019-2030)
2.3 Global Propofol Injection for Operation General Anesthesia Sales Estimates and Forecasts 2019-2030
2.4 Global Propofol Injection for Operation General Anesthesia Sales by Region
2.4.1 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Propofol Injection for Operation General Anesthesia Sales by Region (2019-2024)
2.4.3 Global Propofol Injection for Operation General Anesthesia Sales by Region (2025-2030)
2.4.4 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers
3.1.1 Global Propofol Injection for Operation General Anesthesia Sales by Manufacturers (2019-2024)
3.1.2 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Propofol Injection for Operation General Anesthesia in 2023
3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers
3.2.1 Global Propofol Injection for Operation General Anesthesia Revenue by Manufacturers (2019-2024)
3.2.2 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Propofol Injection for Operation General Anesthesia Revenue in 2023
3.3 Global Key Players of Propofol Injection for Operation General Anesthesia, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Propofol Injection for Operation General Anesthesia Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Propofol Injection for Operation General Anesthesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Propofol Injection for Operation General Anesthesia, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Propofol Injection for Operation General Anesthesia, Product Offered and Application
3.8 Global Key Manufacturers of Propofol Injection for Operation General Anesthesia, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Propofol Injection for Operation General Anesthesia Sales by Specification
4.1.1 Global Propofol Injection for Operation General Anesthesia Historical Sales by Specification (2019-2024)
4.1.2 Global Propofol Injection for Operation General Anesthesia Forecasted Sales by Specification (2025-2030)
4.1.3 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Specification (2019-2030)
4.2 Global Propofol Injection for Operation General Anesthesia Revenue by Specification
4.2.1 Global Propofol Injection for Operation General Anesthesia Historical Revenue by Specification (2019-2024)
4.2.2 Global Propofol Injection for Operation General Anesthesia Forecasted Revenue by Specification (2025-2030)
4.2.3 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Specification (2019-2030)
4.3 Global Propofol Injection for Operation General Anesthesia Price by Specification
4.3.1 Global Propofol Injection for Operation General Anesthesia Price by Specification (2019-2024)
4.3.2 Global Propofol Injection for Operation General Anesthesia Price Forecast by Specification (2025-2030)
5 Market Size by Application
5.1 Global Propofol Injection for Operation General Anesthesia Sales by Application
5.1.1 Global Propofol Injection for Operation General Anesthesia Historical Sales by Application (2019-2024)
5.1.2 Global Propofol Injection for Operation General Anesthesia Forecasted Sales by Application (2025-2030)
5.1.3 Global Propofol Injection for Operation General Anesthesia Sales Market Share by Application (2019-2030)
5.2 Global Propofol Injection for Operation General Anesthesia Revenue by Application
5.2.1 Global Propofol Injection for Operation General Anesthesia Historical Revenue by Application (2019-2024)
5.2.2 Global Propofol Injection for Operation General Anesthesia Forecasted Revenue by Application (2025-2030)
5.2.3 Global Propofol Injection for Operation General Anesthesia Revenue Market Share by Application (2019-2030)
5.3 Global Propofol Injection for Operation General Anesthesia Price by Application
5.3.1 Global Propofol Injection for Operation General Anesthesia Price by Application (2019-2024)
5.3.2 Global Propofol Injection for Operation General Anesthesia Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Propofol Injection for Operation General Anesthesia Market Size by Specification
6.1.1 US & Canada Propofol Injection for Operation General Anesthesia Sales by Specification (2019-2030)
6.1.2 US & Canada Propofol Injection for Operation General Anesthesia Revenue by Specification (2019-2030)
6.2 US & Canada Propofol Injection for Operation General Anesthesia Market Size by Application
6.2.1 US & Canada Propofol Injection for Operation General Anesthesia Sales by Application (2019-2030)
6.2.2 US & Canada Propofol Injection for Operation General Anesthesia Revenue by Application (2019-2030)
6.3 US & Canada Propofol Injection for Operation General Anesthesia Market Size by Country
6.3.1 US & Canada Propofol Injection for Operation General Anesthesia Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Propofol Injection for Operation General Anesthesia Sales by Country (2019-2030)
6.3.3 US & Canada Propofol Injection for Operation General Anesthesia Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Propofol Injection for Operation General Anesthesia Market Size by Specification
7.1.1 Europe Propofol Injection for Operation General Anesthesia Sales by Specification (2019-2030)
7.1.2 Europe Propofol Injection for Operation General Anesthesia Revenue by Specification (2019-2030)
7.2 Europe Propofol Injection for Operation General Anesthesia Market Size by Application
7.2.1 Europe Propofol Injection for Operation General Anesthesia Sales by Application (2019-2030)
7.2.2 Europe Propofol Injection for Operation General Anesthesia Revenue by Application (2019-2030)
7.3 Europe Propofol Injection for Operation General Anesthesia Market Size by Country
7.3.1 Europe Propofol Injection for Operation General Anesthesia Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Propofol Injection for Operation General Anesthesia Sales by Country (2019-2030)
7.3.3 Europe Propofol Injection for Operation General Anesthesia Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Propofol Injection for Operation General Anesthesia Market Size
8.1.1 China Propofol Injection for Operation General Anesthesia Sales (2019-2030)
8.1.2 China Propofol Injection for Operation General Anesthesia Revenue (2019-2030)
8.2 China Propofol Injection for Operation General Anesthesia Market Size by Application
8.2.1 China Propofol Injection for Operation General Anesthesia Sales by Application (2019-2030)
8.2.2 China Propofol Injection for Operation General Anesthesia Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Propofol Injection for Operation General Anesthesia Market Size by Specification
9.1.1 Asia Propofol Injection for Operation General Anesthesia Sales by Specification (2019-2030)
9.1.2 Asia Propofol Injection for Operation General Anesthesia Revenue by Specification (2019-2030)
9.2 Asia Propofol Injection for Operation General Anesthesia Market Size by Application
9.2.1 Asia Propofol Injection for Operation General Anesthesia Sales by Application (2019-2030)
9.2.2 Asia Propofol Injection for Operation General Anesthesia Revenue by Application (2019-2030)
9.3 Asia Propofol Injection for Operation General Anesthesia Sales by Region
9.3.1 Asia Propofol Injection for Operation General Anesthesia Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Propofol Injection for Operation General Anesthesia Revenue by Region (2019-2030)
9.3.3 Asia Propofol Injection for Operation General Anesthesia Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Market Size by Specification
10.1.1 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Sales by Specification (2019-2030)
10.1.2 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Revenue by Specification (2019-2030)
10.2 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Market Size by Application
10.2.1 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Sales by Country
10.3.1 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Propofol Injection for Operation General Anesthesia Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Information
11.1.2 Aspen Pharma Overview
11.1.3 Aspen Pharma Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Aspen Pharma Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aspen Pharma Recent Developments
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Information
11.2.2 Fresenius-Kabi Overview
11.2.3 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius-Kabi Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AbbVie Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Information
11.4.2 Baxter Healthcare Overview
11.4.3 Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Healthcare Recent Developments
11.5 B.Braun
11.5.1 B.Braun Company Information
11.5.2 B.Braun Overview
11.5.3 B.Braun Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 B.Braun Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B.Braun Recent Developments
11.6 Maruishi
11.6.1 Maruishi Company Information
11.6.2 Maruishi Overview
11.6.3 Maruishi Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Maruishi Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Maruishi Recent Developments
11.7 Piramal
11.7.1 Piramal Company Information
11.7.2 Piramal Overview
11.7.3 Piramal Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Piramal Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Piramal Recent Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Overview
11.8.3 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Pharmaceuticals Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 AstraZeneca Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Nhwa
11.10.1 Nhwa Company Information
11.10.2 Nhwa Overview
11.10.3 Nhwa Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Nhwa Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nhwa Recent Developments
11.11 Hengrui
11.11.1 Hengrui Company Information
11.11.2 Hengrui Overview
11.11.3 Hengrui Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hengrui Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hengrui Recent Developments
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Information
11.12.2 Xi'an Libang Overview
11.12.3 Xi'an Libang Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Xi'an Libang Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Xi'an Libang Recent Developments
11.13 Yichang Humanwell
11.13.1 Yichang Humanwell Company Information
11.13.2 Yichang Humanwell Overview
11.13.3 Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Yichang Humanwell Recent Developments
11.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
11.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
11.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Overview
11.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Propofol Injection for Operation General Anesthesia Industry Chain Analysis
12.2 Propofol Injection for Operation General Anesthesia Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Propofol Injection for Operation General Anesthesia Production Mode & Process
12.4 Propofol Injection for Operation General Anesthesia Sales and Marketing
12.4.1 Propofol Injection for Operation General Anesthesia Sales Channels
12.4.2 Propofol Injection for Operation General Anesthesia Distributors
12.5 Propofol Injection for Operation General Anesthesia Customers
13 Market Dynamics
13.1 Propofol Injection for Operation General Anesthesia Industry Trends
13.2 Propofol Injection for Operation General Anesthesia Market Drivers
13.3 Propofol Injection for Operation General Anesthesia Market Challenges
13.4 Propofol Injection for Operation General Anesthesia Market Restraints
14 Key Findings in The Global Propofol Injection for Operation General Anesthesia Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xi'an Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
听
听
*If Applicable.